SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
FOR IMMEDIATE RELEASE Streamlined Organization Lays Foundation for Company Rebrand RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a...
SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
FOR IMMEDIATE RELEASE RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a global contract development, manufacturing, and analytical testing...
SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure
FOR IMMEDIATE RELEASE PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing...
SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production
FOR IMMEDIATE RELEASE Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong More than 300 new employees...
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
NASHVILLE, Tenn., and RANCHO CORDOVA, Ca. – September 25, 2024 – Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global leader in...
SK pharmteco’s Swords Facility Celebrates 60 Years of Pharmaceutical Excellence
Swords, Ireland – [August 26, 2024] – SK pharmteco’s Swords facility celebrated its 60th anniversary on August 8th, marking six...
SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing
SEONGNAM, South Korea, Aug. 5, 2024 – SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both...
SK pharmteco Launches New Lentiviral Vector Analytical Services with Dedicated 20,000 sq. ft. Facility
FOR IMMEDIATE RELEASE SK pharmteco Launches New Lentiviral Vector Analytical Services with Dedicated 20,000 sq. ft. Facility King of Prussia,...
Ferring Pharmaceuticals and SK pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved Adstiladrin® (nadofaragene firadenovec-vncg) The deal...